Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1994-5-2
pubmed:abstractText
To evaluate the efficacy of high-dose verapamil treatment (240 mg twice daily) in the prevention of angiographic restenosis after primary successful coronary angioplasty in patients at high risk of recurrent obstruction.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-1617762, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-1967557, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-1994661, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2188991, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2299089, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2401061, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2524293, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2928338, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2933441, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2936532, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2943782, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2946740, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2949590, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2961550, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2962786, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2967433, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2969017, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-2969925, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3156011, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3156480, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3158187, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3161734, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3348836, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3489893, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3606723, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3689205, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-3967343, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-449946, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-6362387, http://linkedlifedata.com/resource/pubmed/commentcorrection/8142195-6453256
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-0769
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
254-60
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.
pubmed:affiliation
Abteilung Kardiologie, Angiologie, Pulmologie, Universität Heidelberg, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't